Somewhat Positive News Coverage Somewhat Unlikely to Affect Halyard Health (HYH) Share Price

Media headlines about Halyard Health (NYSE:HYH) have been trending somewhat positive on Monday, according to Accern. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Halyard Health earned a daily sentiment score of 0.20 on Accern’s scale. Accern also gave media stories about the medical instruments supplier an impact score of 45.4996269324515 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

Several equities analysts recently issued reports on the company. BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Deutsche Bank AG upped their price objective on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a research report on Thursday, August 3rd. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research report on Wednesday, July 12th. Finally, TheStreet raised Halyard Health from a “c” rating to a “b” rating in a research report on Thursday, June 22nd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $42.25.

Shares of Halyard Health (NYSE HYH) opened at 45.83 on Monday. The firm’s 50-day moving average is $42.57 and its 200-day moving average is $39.44. The stock has a market capitalization of $2.14 billion, a price-to-earnings ratio of 44.07 and a beta of 1.76. Halyard Health has a 52 week low of $31.59 and a 52 week high of $46.15.

Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The business had revenue of $399.20 million during the quarter, compared to the consensus estimate of $399.16 million. During the same period in the previous year, the firm posted $0.45 earnings per share. The business’s revenue for the quarter was down .2% compared to the same quarter last year. Analysts forecast that Halyard Health will post $1.98 earnings per share for the current fiscal year.

WARNING: This story was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.themarketsdaily.com/2017/09/11/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-halyard-health-hyh-share-price.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Insider Buying and Selling by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply